Tag Archives: narrative review
Tirzepatide and Semaglutide: 15-20% in a New Review
Tirzepatide and semaglutide give 15 to 20 percent mean weight loss over 12 to 18 months, a new narrative review reports, with wider gains.
Anti-Obesity Medications and Ageing: What a 2026 Review Reports
A narrative review published in August 2026 maps what anti-obesity medications appear to do beyond weight loss, from cardiovascular outcomes to skin laxity, and states plainly where the evidence stops short.